Amphastar Pharmaceuticals, Inc. (29A.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:13AM CEST
| Previous close | 37.71 |
| Open | 37.64 |
| Bid | 38.27 x 70000 |
| Ask | 38.79 x 70000 |
| Day's range | 37.64 - 37.64 |
| 52-week range | 32.00 - 59.00 |
| Volume | |
| Avg. volume | 9 |
| Market cap | 1.873B |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | 15.55 |
| EPS (TTM) | 2.42 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 22.75 |
Simply Wall St.Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth
Amphastar Pharmaceuticals, Inc. ( NASDAQ:AMPH ) shareholders might be concerned after seeing the share price drop 26...
ZacksAmphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $41.52, representing a -1% change from its previous close.
ZacksIs Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Amphastar (AMPH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
© 2024 Yahoo. All rights reserved.